A new approach to major health conditions
Steve How and Oli Hudson, of Wilmington Healthcare, explore the NHS Long Term Plan’s vision to deliver more preventative, joined-up services for key illnesses
PharmaTimes -
June 2019
The wait is over – we’re thrilled to announce that four highly respected PharmaTimes competitions – the Sales Awards, Marketer of the Year, Communications Team of the Year and the Medical and Scientific Excellence Awards – are now open for entry. For more information on how to secure your chance to benchmark your skill set against the best and take home a coveted Pharma award, see www.pharmatimes.com/competitions.
Also, in this issue we unveil winners of the PharmaTimes Clinical Researcher of the Year – The Americas competition (p24). A huge congratulations to all the finalists and PRA Health Sciences, who took home the Clinical Research Company of the Year award for the seventh time!
Sticking with clinical research, on page 26 there’s a look at the promise of virtual clinical trials in engaging and empowering patients within the research process, while also expanding the pool of potential participants.
Elsewhere, our cover feature (p31) explores new approaches to pharma sales, while the team at Wilmington Healthcare looks at the NHS Long Term Plan’s vision to deliver more preventative, joined-up services for key illnesses, with three clear themes emerging: the need to risk stratify patients, engage them in their treatment and also encourage lifestyle changes (p16).
I hope you enjoy the issue!
June 2019 - magazine highlights
SmartPeople: Dr Tim Guilliams
Dr Tim Guilliams is on a mission to help rare disease patients access life-saving treatments. Here he gives an insight into his role as co-founder and chief executive of Healx, and the promise of artificial intelligence
Clinical Researcher of the Year – The Americas: Winners announced!
Who took home a Pharma award at the PharmaTimes Clinical Researcher of the Year 2019 competition?
Going virtual?
Lindsay McNair and Josh Rose explore the status quo for virtual clinical trials
GSK and the trouble with vaccines in Africa
Ana Nicholls on Malawi's new anti-malaria vaccination programme, and GlaxoSmithKline's wider position in the field
Drugging the ‘undruggables’
Mani Krishnan on the renaissance of oligonucleotide therapies
Flight of the navigators
Sales in pharma is a frequently changing canvass. Its leveraging of technology has triggered new, bold approaches, while also upholding a fine tradition of individuality among its multifarious and talented workforce. Finding the most compelling mix of human attributes and digital dynamism holds the key to sustained pharma sales success – indeed, it is an industry artform
Early access
Lorenzo D’Angelo on strategies for implementing successful pre-launch access programmes
A roadmap to navigate telehealth
The business potential of telehealth is tremendous in a world in which quality and access to care are of growing importance, but the new challenges it poses cannot be addressed within the borders of our traditional areas of the law
A collaborative approach
The viability and value of continuous bioprocessing is now irrefutable, but pharma will need to work with regulators and get the right data to overcome any roadblocks
Company focus: bluebird bio
Andrew Obenshain, senior vice president and head of Europe at bluebird bio, introduces the company and discusses the challenges and opportunities of gene therapy
Patient Files: Malaria
Laurie Griffiths contracted malaria while travelling in Africa. He tells PharmaTimes his story
